Tenon Medical, Inc. (TNON)
NASDAQ: TNON · IEX Real-Time Price · USD
0.651
-0.016 (-2.40%)
At close: Jul 19, 2024, 4:00 PM
0.670
+0.019 (2.92%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Tenon Medical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Tenon Medical stock has a target of 3.00, which predicts an increase of 360.83% from the current stock price of 0.65.
Analyst Consensus: Buy
* Price targets were last updated on Apr 15, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for Tenon Medical is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Maintains $5 → $3 | Buy | Maintains | $5 → $3 | +360.83% | Apr 15, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +9,116.59% | Mar 10, 2023 |
| Benchmark | Benchmark | Buy Initiates $60 | Buy | Initiates | $60 | +9,116.59% | Jun 21, 2022 |
Financial Forecast
Revenue This Year
4.64M
from 2.93M
Increased by 58.37%
Revenue Next Year
9.17M
from 4.64M
Increased by 97.80%
EPS This Year
-4.22
from -8.59
EPS Next Year
-3.21
from -4.22
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 4.9M | 11.0M |
| Avg | 4.6M | 9.2M |
| Low | 4.3M | 7.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | 67.7% | 137.2% |
| Avg | 58.4% | 97.8% |
| Low | 47.8% | 58.7% |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -3.68 | -1.94 |
| Avg | -4.22 | -3.21 |
| Low | -4.68 | -4.36 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.